News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fujisawa Pharmaceutical Co., Ltd. To Outsource Cefzon Bulk Production To API Corporation



10/19/2005 5:13:07 PM

Tokyo (JCNN) - Fujisawa Pharmaceutical announced on March 23 that the company has agreed with API Corporation on the bulk production of Cefzon, Fujisawa's proprietary oral cepharosporin antibiotic. Under the terms of the agreement, API will handle production for overseas use and supply Fujisawa with Cefzon bulk.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES